Wu Yusheng, the chairman, executive director, and president of TYK MEDICINES-B (02410), intends to increase his shareholding in the company.

Tongyuan Kang Medicine-B (02410) announced that the company's Chairman, Executive Director, and President Dr. Wu Yusheng has informed the company that he recently purchased shares of the company on the open market and may continue to buy additional shares depending on market conditions in the future, with an expected total investment not exceeding HKD 2 million. Dr. Wu has committed to the company that the shares acquired through this increase will be voluntarily locked up for six months starting from the date of purchase, and he will not sell or transfer the relevant shares in any way during the lock-up period. Dr. Wu stated that the funds for this share purchase come from his own resources. This share acquisition demonstrates his strong belief and complete confidence in the future development prospects of the group.